申请人:YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD.
公开号:EP0596120A1
公开(公告)日:1994-05-11
A thiophene compound represented by general formula (I), a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising this compound and pharmaceutical additives, and an antipsychotic containing this compound as the active ingredient; wherein each symbol is as defined in the specification. This compound has pharmacological activities necessary for an antipsychotic, such as, inhibition of active exercise, antiapomorphine activity, methaphetamine antogonism, and potentiation of tetrabenazine-induced blepharoptosis. It is also useful as an antipsychotic which is reduced in the side effect against an extrapyramidal system and as a non-benzodiazepine ataractic.
一种由通式(I)代表的噻吩化合物、其药学上可接受的盐、一种由该化合物和药用添加剂组成的药物组合物,以及一种含有该化合物作为活性成分的抗精神病药;其中各符号如说明书中所定义。该化合物具有抗精神病药所需的药理活性,如抑制主动运动、抗阿片类活性、甲基苯丙胺抗兴奋性和增强四苯嗪诱导的睑裂。作为一种抗精神病药,它还能减少对锥体外系的副作用,同时也是一种非苯二氮卓类药物。